| Author | : NPCS board |
| File Size | : 41,6 Mb |
| Publisher | : NIIR PROJECT CONSULTANCY SERVICES |
| Language | : English |
| Release Date | : 01 October 2013 |
| ISBN | : 9789381039212 |
| Pages | : 117 pages |
Investment Opportunity in Drugs Pharmaceutical Projects by NPCS board Book PDF Summary
(LIMITED EDITION- ONLY PHOTOSTAT COPY AVAILABLE) Drugs and pharmaceutical industry plays a vital role in the economic development of a nation. It is one of the largest and most advanced sectors in the world, acting as a source for various drugs, medicines and their intermediates as well as other pharmaceutical formulations. The Indian drugs and pharmaceutical industry, over the years, has shown tremendous progress in terms of infrastructure development, technology base creation as well as product usage. The pharmaceutical industry has been one of the fastest growing segments of the Indian manufacturing sector with an average annual growth rate of about 14% and is projected to grow at an average annual rate exceeding 15%. This growth would be fuelled mainly by (i) access to low cost and high volume of generic drugs, (ii) mergers and acquisitions, (iv) industry consolidation, and (v) high growth of contract manufacturing. The pharmaceutical industry has been producing bulk drugs belonging to all major therapeutic groups requiring complicated manufacturing processes as well as a wide range of pharma machinery and equipments. India has carved a niche for itself by being a top generic Pharma player. Indian Pharmaceutical Industry is playing a key role in promoting and sustaining development in the vital field of medicines. This book contains information on L-Ascorbic Acid, Pharmaceutical Unit, Liquid Glucose, Glucose Saline, IV Fluids, Paracetamol, Sorbitol, Aspirin and Ibuprofen along with their manufacturing process, producers, plant economics etc. This book also throws light on Drugs and Pharmaceutical Industries in India. This book will give a thorough knowledge of the contents that it covers and also about the scenario of the Pharmaceutical Industry.